| Literature DB >> 30791395 |
Ivica Blažević1, Azra Đulović2, Vedrana Čikeš Čulić3, Franko Burčul4, Ivica Ljubenkov5, Mirko Ruščić6, Ivana Generalić Mekinić7.
Abstract
Bunias erucago belongs to the Brassicaceae family, which represents a forgotten crop of the Euro-Mediterranean area. The aim of the present study was to determine the glucosinolate profile in different plant parts and biological properties (antioxidant, anticholinesterase, and cytotoxic activities) of the isolates containing glucosinolate breakdown products. The chemical profiles were determined by using HPLC-PDA-MS/MS of desulfoglucosinolates and GC-MS of glucosinolate degradation products. The analysis of B. erucago showed the presence of seven glucosinolates: gluconapin (1), glucoraphasatin (2), glucoraphenin (3), glucoerucin (4), glucoraphanin (5), glucotropaeolin (6), and glucosinalbin (7). The total glucosinolate content ranged from 7.0 to 14.6 µmol/g of dry weight, with the major glucosinolate glucosinalbin in all parts. The antioxidant activity of all volatile isolates was not notable. At a tested concentration of 227 μg/mL, flower hydro-distillate (FH) showed good AChE inhibition, i.e., 40.9%, while root hydro-distillate (RH) had good activity against BChE, i.e., 54.3%. FH showed the best activity against both tested human bladder cancer cell lines, i.e., against T24 after 72 h, which have IC50 of 16.0 μg/mL, and against TCCSUP after 48 h with IC50 of 7.8 μg/mL, and can be considered as highly active. On the other hand, RH showed weak activity against tested cancer cells.Entities:
Keywords: Bunias erucago L.; anti-oxidation; cholinesterase inhibition; cytotoxic activity; desulfoglucosinolates; glucosinolates; isothiocyanates; nitriles
Mesh:
Substances:
Year: 2019 PMID: 30791395 PMCID: PMC6412829 DOI: 10.3390/molecules24040741
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Individual concentrations of glucosinolates (μmol/g dw) in B. erucago tissues.
| Glucosinolate | Flower | Leaf and Stem | Root | |
|---|---|---|---|---|
| Glucoraphanin ( | 8.1 | 0.3 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 |
| Glucoraphenin ( | 8.4 | 5.7 ± 0.8 | 1.0 ± 0.2 | 1.6 ± 0.4 |
| Glucosinalbin ( | 11.3 | 6.8 ± 0.5 | 5.6 ± 0.9 | 8.3 ± 1.0 |
| Gluconapin ( | 12.1 | 0.6 ± 0.1 | 0.2 ± 0.0 | 0.5 ± 0.1 |
| Glucotropaeolin ( | 18.2 | 0.2 ± 0.0 | 0.1 ± 0.0 | 0.2 ± 0.0 |
| Glucoerucin ( | 18.9 | - | - | tr |
| Glucoraphasatin ( | 19.5 | 1.0 ± 0.2 | - | 2.2 ± 0.2 |
| Total (μmol/g dry weight) | 14.6 ± 1.6 | 7.0 ± 1.1 | 12.9 ± 1.7 |
dw, dry weight; tr < 0.1 μmol/g dw; -, not detected.
Glucosinolates, their breakdown products, and other volatiles identified in different parts of B. erucago by GC-MS.
| Hydrodistilate | Extract | |||||
|---|---|---|---|---|---|---|
| Glucosinolate | Identified Breakdown Compound | RI | Flower | Leaf and Stem | Root | Whole Plant Material |
| Gluconapin ( | But-3-enyl ITC a,b,c | 993 | 0.8 | 2.0 | 10.3 | - |
| Glucotropaeolin ( | 2-Phenylacetonitrile a,b | 1178 | 1.0 | tr | - | - |
| Benzyl ITC a,b | 1394 | - | - | tr | - | |
| Glucoraphasatin ( | 5-(Methylsulfanyl)pent-4-enenitrile *,a,b | 1214 | 14.5 | - | 1.4 | - |
| 5-(Methylsulfanyl)pent-4-enenitrile *,a,b | 1251 | 4.7 | - | 1.0 | - | |
| 4-(Methylsulfanyl)but-3-enyl ITC a,b,c | 1440 | 0.1 | - | 2.4 | - | |
| Glucoerucin ( | 4-(Methylsulfanyl)pentanenitrile a,b,c | 1233 | 2.3 | - | - | - |
| 4-(Methylsulfanyl)butyl ITC (erucin) a,c | 1457 | - | - | 1.1 | - | |
| Glucoraphenin ( | 4-(Methylsulfinyl)but-3-enyl ITC a,c | 1817 | - | - | - | 88.3 |
|
| ||||||
| 1,2-Dimethylbenzene b | 874 | 3.9 | 0.8 | 4.0 | - | |
| 3-Methylsulfanylpropanal b | 919 | - | - | 0.3 | - | |
| Dimethyltrisulfide a,b | 981 | tr | - | 9.4 | - | |
| Benzeneacetaldehyde a,b | 1063 | 0.5 | 1.1 | 1.3 | - | |
| ( | 1113 | 1.3 | 0.8 | 0.5 | - | |
| Dimethyltetrasulfide a,b | 1235 | - | - | 0.3 | - | |
| 4-Vinyl-2-methoxyphenol a,b | 1353 | 0.7 | 0.8 | tr | - | |
| ( | 1492 | 1.8 | - | - | - | |
| Tetradecanoic acid a,b | 1828 | 3.9 | 18.3 | 6.7 | - | |
| 6,10,14-Trimethylpentadecan-2-one a,b | 1854 | 28.2 | 25.5 | 1.9 | - | |
| Hexadecanoic acid a,b | 2016 | 24.6 | 39.8 | 53.5 | 6.1 | |
| Total sum (%) | 88.3 | 89.1 | 94.1 | 94.4 | ||
RI, Retention indices determined on a VF-5MS capillary column. -, not detected. tr, traces. *, correct isomer is not identified. ITC, isothiocyanate. a Compound identified by mass spectra and RI comparison with own library. b Compound identified by mass spectra comparison with Wiley library. c Compound identified by mass spectra comparison with literature values [18,19,20,21].
Figure 1Glucosinolates identified in different parts of B. erucago.
Antioxidant and cholinesterase inhibitory activity of volatile isolates from Bunias erucago.
| Flower Hydro-Distillate (FH) | Root Hydro-Distillate (RH) | |
|---|---|---|
|
| ||
| DPPH (Inhibition %) | 9.6 ± 0.4 | 10.2 ± 1.4 |
| FRAP (µM Fe2+) | 41.7 ± 0.9 | 24.3 ± 0.1 |
|
| ||
| AChE (Inhibition %) | 40.9 ± 0.2 | 13.7 ± 0.2 |
| BChE (Inhibition %) | 25.0 ± 0.1 | 54.3 ± 0.3 |
DPPH—2,2-Diphenyl-1-picrylhydrazyl. FRAP—Ferric Reducing Antioxidant Power. AChE—acetylcholinesterase inhibitory activity. BChE—butyrylcholinesterase inhibitory activity. All samples were tested in triplicates, at final concentrations for DPPH, FRAP, and AChE/BChE of 166, 161, and 227 μg/mL, respectively.
Figure 2Percentage of metabolically active human bladder cancer cells T24 and TCCSUP after 4, 24, 48, and 72 h of incubation with different concentrations of B. erucago hydro-distillate from the flower and roots tested.
Cytotoxic activity of volatile isolates from Bunias erucago against two human bladder cancer cell lines (T24, TCCSUP) expressed as IC50 values (μg/mL).
| Flower Hydro-Distillate (FH) | Root Hydro-Distillate (RH) | |||||||
|---|---|---|---|---|---|---|---|---|
| 4 h | 24 h | 48 h | 72 h | 4 h | 24 h | 48 h | 72 h | |
| T24 | 362.6 | 21.4 | 23.8 | 16.0 | 517.7 | 267.5 | 676.0 | 366.8 |
| TCCSUP | 418.4 | 15.2 | 7.8 | 49.9 | 519.1 | 326.0 | 258.3 | 316.9 |